| Cover | Jan. 13, 2021 |
| Document Information [Line Items] | |
| Document Type | 8-K |
| Document Period End Date | Jan. 13, 2021 |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-36399 |
| Entity Tax Identification Number | 42-1560076 |
| Entity Address, Address Line One | 1900 Powell Street |
| Entity Address, Address Line Two | Suite 1000 |
| Entity Address, City or Town | Emeryville |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94608 |
| City Area Code | 510 |
| Local Phone Number | 450-3500 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.001 per share |
| Trading Symbol | ADMS |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Entity Central Index Key | 0001328143 |
| Amendment Flag | false |
| Entity Registrant Name | ADAMAS PHARMACEUTICALS, INC. |
